我国明年起禁止生产含汞体温计和含汞血压计产品，这些企业生产相关替代产品

Industry Overview - The National Medical Products Administration of China will ban the production of mercury thermometers and sphygmomanometers starting January 1, 2026, marking the end of mercury-based medical devices [1] - Electronic thermometers and blood pressure monitors have become mainstream alternatives, with a significant market opportunity as the penetration rate of home electronic blood pressure monitors in China is only 5%-10%, compared to over 50% in the US and Japan [1] - Advances in sensor technology, big data analytics, and artificial intelligence are expected to enhance the measurement accuracy and smart features of electronic thermometers [1] - AI algorithms in electronic thermometers can predict the likelihood of fever, improving user experience [1] - Next-generation electronic blood pressure monitors, especially those using the Korotkoff sound method with AI capabilities, are anticipated to effectively replace mercury sphygmomanometers in both clinical and home settings [1] Company Insights - Leshi Medical holds approximately 9.2% market share in the electronic thermometer market in 2023, ranking third in the industry, with a focus on "health management" through smart wearable thermometers integrated with mobile apps [2] - Kefu Medical is continuously expanding its product range and improving quality and technology, offering high-quality best-selling products including electronic blood pressure monitors, nursing beds, infrared thermometers, hearing aids, and nebulizers [2]